Cargando…
Design of new drugs for medullary thyroid carcinoma
Medullary thyroid carcinoma (MTC) is one of the common malignant endocrine tumors, which seriously affects human health. Although surgical resection offers a potentially curative therapeutic option to some MTC patients, most patients do not benefit from it due to the difficulty to access the tumors...
Autores principales: | Li, Yanqing, Luo, Ziyu, Wang, Xinxing, Zhang, Songtao, Hei, Hu, Qin, Jianwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760674/ https://www.ncbi.nlm.nih.gov/pubmed/36544713 http://dx.doi.org/10.3389/fonc.2022.993725 |
Ejemplares similares
-
Anlotinib in patients with medullary thyroid carcinoma with negative prognostic factors: A sub-analysis based on the ALTER01031 study
por: Zhao, Jingzhu, et al.
Publicado: (2022) -
Nomogram for preoperative estimation risk of cervical lymph node metastasis in medullary thyroid carcinoma
por: Luo, Zhiyan, et al.
Publicado: (2022) -
Targeted Therapy for Medullary Thyroid Cancer: A Review
por: Priya, S. R., et al.
Publicado: (2017) -
Hormone Receptor Status May Impact the Survival Benefit Between Medullary Breast Carcinoma and Atypical Medullary Carcinoma of the Breast: A Population-Based Study
por: Qin, Wenxing, et al.
Publicado: (2021) -
Thyroid: Medullary Carcinoma
por: Somnay, Yash R., et al.
Publicado: (2013)